Background Patients with ulcerative colitis (UC) have an increased risk of developing
colorectal cancer (CRC); however, the magnitude of this effect is open to debate. Aim To …

The risk of colorectal cancer for any patient with ulcerative colitis is known to be elevated,
and is estimated to be 2% after 10 years, 8% after 20 years and 18% after 30 years of …

BACKGROUND & AIMS: Patients with ulcerative colitis (UC) have an increased risk of
developing colorectal cancer (CRC). Studies examining the magnitude of this association …

Background Recently reported risks of colorectal cancer (CRC) in inflammatory bowel
disease (IBD) have been lower than those reported before 2000. The aim of this meta …

Background: Inflammatory bowel disease (IBD) is commonly treated with immunomodulators
such as azathioprine and 6-mercaptopurine (6-MP). Studies examining lymphoma risk in …

The association between inflammatory bowel disease (IBD) and colorectal cancer (CRC)
has been recognised since 1925 and still accounts for 10%-15% of deaths in IBD. IBD …

OBJECTIVES: Extra-intestinal manifestations of inflammatory bowel disease (IBD) are
relatively common, whereas the risk of extra-intestinal cancer (EIC) remains uncertain. The …

Background & Aims Patients with Crohn's disease (CD) and ulcerative colitis (UC) are at
increased risk of developing intestinal cancer. However, less is known about the risk of …

Background & aims: Ulcerative colitis (UC) is associated with an increased risk for colorectal
cancer (CRC) and possibly also increased risk for cancers outside the intestinal tract. We …

Background & Aims: Previous studies of the risk of lymphoma in inflammatory bowel disease
patients have provided conflicting results. This study examines the risk of Hodgkin's and non …